202 related articles for article (PubMed ID: 36967754)
1. Analysis of cumulative outcomes and influencing factors of patients with discrepancies between age and AMH levels in the early follicular phase prolonged protocol.
Wang K; Guan Y; Zhang Y; Jia R; Wu S; Yao Z; Zhang M; Li Z
Front Endocrinol (Lausanne); 2023; 14():1098131. PubMed ID: 36967754
[TBL] [Abstract][Full Text] [Related]
2. [Effects of time of recombinant luteinized hormone supplementation on pregnancy outcomes of women with advanced reproductive age during follicular-phase long protocol].
Wang L; Wang J; Hu YQ; Liu JY; Diao FY
Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):758-766. PubMed ID: 36299179
[No Abstract] [Full Text] [Related]
3. IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels.
Zhang B; Meng Y; Jiang X; Liu C; Zhang H; Cui L; Chen ZJ
Reprod Biol Endocrinol; 2019 Jul; 17(1):58. PubMed ID: 31311571
[TBL] [Abstract][Full Text] [Related]
4. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.
Li Z; Jia R; Wang K; Zhang J; Ren B; Guan Y
Front Endocrinol (Lausanne); 2022; 13():938500. PubMed ID: 35992097
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients.
Guo Y; Jiang H; Hu S; Liu S; Li F; Jin L
J Ovarian Res; 2021 Aug; 14(1):111. PubMed ID: 34454544
[TBL] [Abstract][Full Text] [Related]
7. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
8. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).
Lin WQ; Yao LN; Zhang DX; Zhang W; Yang XJ; Yu R
J Assist Reprod Genet; 2013 Jun; 30(5):649-55. PubMed ID: 23504440
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
[TBL] [Abstract][Full Text] [Related]
11. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
[TBL] [Abstract][Full Text] [Related]
12. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
13. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
[TBL] [Abstract][Full Text] [Related]
14. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
16. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
17. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
18. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China.
Liu L; Sun XY; Yang H; Feng XJ; Lan YZ
Reprod Health; 2022 Dec; 19(1):224. PubMed ID: 36514055
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study.
Hou Y; Wang L; Li Y; Ai J; Tian L
Sci Rep; 2023 Feb; 13(1):2127. PubMed ID: 36746984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]